Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 3
2010 3
2011 3
2012 7
2013 6
2014 5
2015 6
2016 3
2017 6
2018 6
2019 8
2020 11
2021 13
2022 18
2023 13
2024 13
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Chu et al.
Ackerson B, Bruxvoort K, Qian L, Sy LS, Tseng HF. Ackerson B, et al. Among authors: sy ls. J Infect Dis. 2023 Feb 1;227(3):466-467. doi: 10.1093/infdis/jiac310. J Infect Dis. 2023. PMID: 35880546 No abstract available.
The Authors Reply.
Xu S, Sy LS. Xu S, et al. Among authors: sy ls. Am J Epidemiol. 2024 Aug 6:kwae267. doi: 10.1093/aje/kwae267. Online ahead of print. Am J Epidemiol. 2024. PMID: 39108180 No abstract available.
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Ackerson BK, Bruxvoort KJ, Qian L, Sy LS, Qiu S, Tubert JE, Lee GS, Ku JH, Florea A, Luo Y, Bathala R, Stern J, Choi SK, Takhar HS, Aragones M, Marks MA, Anderson EJ, Zhou CK, Sun T, Talarico CA, Tseng HF. Ackerson BK, et al. Among authors: sy ls. Hum Vaccin Immunother. 2024 Dec 31;20(1):2335052. doi: 10.1080/21645515.2024.2335052. Epub 2024 Apr 4. Hum Vaccin Immunother. 2024. PMID: 38575149 Free PMC article.
Mortality risk after COVID-19 vaccination: A self-controlled case series study.
Xu S, Sy LS, Hong V, Farrington P, Glenn SC, Ryan DS, Shirley AM, Lewin BJ, Tseng HF, Vazquez-Benitez G, Glanz JM, Fireman B, McClure DL, Hurley LP, Yu O, Wernecke M, Smith N, Weintraub ES, Qian L. Xu S, et al. Among authors: sy ls. Vaccine. 2024 Mar 7;42(7):1731-1737. doi: 10.1016/j.vaccine.2024.02.032. Epub 2024 Feb 22. Vaccine. 2024. PMID: 38388239 Free PMC article.
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection.
Malden DE, Liu IA, Qian L, Sy LS, Lewin BJ, Asamura DT, Ryan DS, Bezi C, Williams JTB, Kaiser R, Daley MF, Nelson JC, McClure DL, Zerbo O, Henninger ML, Fuller CC, Weintraub ES, Saydah S, Tartof SY. Malden DE, et al. Among authors: sy ls. Nat Commun. 2024 May 22;15(1):4101. doi: 10.1038/s41467-024-48022-9. Nat Commun. 2024. PMID: 38778026 Free PMC article.
Pediatric Vaccination During the COVID-19 Pandemic.
Ackerson BK, Sy LS, Glenn SC, Qian L, Park CH, Riewerts RJ, Jacobsen SJ. Ackerson BK, et al. Among authors: sy ls. Pediatrics. 2021 Jul;148(1):e2020047092. doi: 10.1542/peds.2020-047092. Epub 2021 Apr 15. Pediatrics. 2021. PMID: 33858983
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States.
Tseng HF, Ackerson BK, Sy LS, Tubert JE, Luo Y, Qiu S, Lee GS, Bruxvoort KJ, Ku JH, Florea A, Takhar HS, Bathala R, Zhou CK, Esposito DB, Marks MA, Anderson EJ, Talarico CA, Qian L. Tseng HF, et al. Among authors: sy ls. Nat Commun. 2023 Sep 20;14(1):5851. doi: 10.1038/s41467-023-41537-7. Nat Commun. 2023. PMID: 37730701 Free PMC article.
113 results